COMMENTARY ON:Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Cairo S, Wang Y, de Reyniès A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA. PNAS, 2010, November 23, 107(47), 20471–20476. Copyright (2010) by the National Academy of Sciences. Abstract reprinted with permission from the National Academy of Sciences.http://www.ncbi.nlm.nih.gov/pubmed/21059911Abstract: Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neoplasm derived from liver progenitor cells. Here, microRNA (miR) expression profiling of 65 HBs evidenced differential patterns related to developmental stage and Myc activity. Undifferentiated aggressive HBs overexpres...
Hepatocellular carcinoma (HCC) is associated with poor survival for patients and few effective treat...
Background & aims: We performed an integrated analysis to identify microRNAs (miRNAs) and mRNAs with...
International audienceMolecular classifications defining new tumor subtypes have been recently refin...
Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neop...
Deregulation of microRNAs (miRNAs) is a typical feature of human hepatocellular carcinoma (HCC). How...
Deregulation of microRNAs (miRNAs) is a typical feature of human hepatocellular carcinoma (HCC). How...
MYC is a noncanonical transcription factor that binds to thousands of genomic loci and affects.15 % ...
Abstract Hepatic cancer stem cells (HCSCs) are considered as main players for the hepatocellular car...
AIM: Hepatocellular carcinoma (HCC), one of the most common malignancies in adults displays aberrant...
Background: Recent research has suggested that the oncomir microRNA 155 (miR-155) is up-regulated in...
Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. Curative option...
The MYC protein controls many cellular processes, including proliferation, cell cycle progression, c...
The human microRNA cluster MC-let-7a-1∼let-7d, with three members let-7a-1, let-7f-1, and let-7d, is...
Comment in Cell Cycle. 2011 Feb 15;10(4):571-572.A novel paradigm in tumor biology suggests that can...
SummaryMicroRNAs (miRNAs) are evolutionary conserved small non-coding RNAs that regulate gene expres...
Hepatocellular carcinoma (HCC) is associated with poor survival for patients and few effective treat...
Background & aims: We performed an integrated analysis to identify microRNAs (miRNAs) and mRNAs with...
International audienceMolecular classifications defining new tumor subtypes have been recently refin...
Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neop...
Deregulation of microRNAs (miRNAs) is a typical feature of human hepatocellular carcinoma (HCC). How...
Deregulation of microRNAs (miRNAs) is a typical feature of human hepatocellular carcinoma (HCC). How...
MYC is a noncanonical transcription factor that binds to thousands of genomic loci and affects.15 % ...
Abstract Hepatic cancer stem cells (HCSCs) are considered as main players for the hepatocellular car...
AIM: Hepatocellular carcinoma (HCC), one of the most common malignancies in adults displays aberrant...
Background: Recent research has suggested that the oncomir microRNA 155 (miR-155) is up-regulated in...
Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. Curative option...
The MYC protein controls many cellular processes, including proliferation, cell cycle progression, c...
The human microRNA cluster MC-let-7a-1∼let-7d, with three members let-7a-1, let-7f-1, and let-7d, is...
Comment in Cell Cycle. 2011 Feb 15;10(4):571-572.A novel paradigm in tumor biology suggests that can...
SummaryMicroRNAs (miRNAs) are evolutionary conserved small non-coding RNAs that regulate gene expres...
Hepatocellular carcinoma (HCC) is associated with poor survival for patients and few effective treat...
Background & aims: We performed an integrated analysis to identify microRNAs (miRNAs) and mRNAs with...
International audienceMolecular classifications defining new tumor subtypes have been recently refin...